Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Decorative image

KDIGO Conversations in Nephrology:

Travere-Sponsored Episodes

This collection of Travere-sponsored episodes from KDIGO Conversations in Nephrology explores the changing paradigm in rare kidney disease. These episodes highlight the evolution of IgA nephropathy care—from advancements in disease understanding to the evolving therapeutic landscape.

Together, these conversations provide an overview of how decades of research, new therapies, and evolving clinical guidance are redefining expectations for patients with rare kidney diseases.

Episodes

Travere and KDIGO Podcast Collaboration – Conversations in Nephrology: Challenges of Implementing Evidence-Based Guidance for IgA Nephropathy
Podcast NephrologyIgAN

Conversations in Nephrology: Challenges of Implementing Evidence-Based Guidance for IgA Nephropathy

Listen to episode
Travere and KDIGO Podcast Collaboration – Conversations in Nephrology: How I Treat IgA Nephrology – Lessons from the Case Files
Podcast NephrologyIgAN

Conversations in Nephrology: How I Treat IgA Nephrology – Lessons from the Case Files

Listen to episode
Travere and KDIGO Podcast Collaboration – Conversations in Nephrology: Treatment Revolution in IgA Nephropathy
Podcast NephrologyIgAN

Conversations in Nephrology: Treatment Revolution in IgA Nephropathy

Listen to episode
Travere and KDIGO Podcast Collaboration – Conversations in Nephrology: Overview of the Latest Guidance in IgA Nephropathy Management
Podcast NephrologyIgAN

Conversations in Nephrology: Overview of the Latest Guidance in IgA Nephropathy Management

Listen to episode

Disclaimer: These episodes of KDIGO Conversations in Nephrology were supported by Travere Therapeutics and developed by Kidney Disease: Improving Global Outcomes. Please always consult updated sources for the latest information, as information discussed may have changed since the recording date.

MA-DS-26-0008 | April 2026